Sulfur mustard-induced ocular surface disorders

Ocular Surface

Volumn 9, Issue 3, 2011, Pages 163-178

  Baradaran Rafii, Alireza ^a   Eslani, Medi ^a   Tseng, Scheffer C G ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b OCULAR SURFACE CENTER   (United States)

Author keywords

Chemical warfare agents; Corneal burns; Corneal transplantation; Mustard gas; Oxidative stress; Sulfur mustard

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; AMYLOID; ANTIBIOTIC AGENT; ARTIFICIAL TEAR; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; DEFEROXAMINE; DEXAMETHASONE; DILTIAZEM; DOXYCYCLINE; FLAVONOID; GALLIUM; IODINE; LIPID; LUBRICATING AGENT; MUSTARD GAS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID; TACROLIMUS; THIOSULFATE; THYMOSIN BETA4; UNINDEXED DRUG; ZINC COMPLEX;

ACUTE GRAFT REJECTION; ALLOGENEIC STEM CELL TRANSPLANTATION; AMNION; AMNIOTIC MEMBRANE TRANSPLANTATION; BLEPHARITIS; BONE MARROW DISEASE; CAUTERIZATION; CHRONIC INFLAMMATION; CLASSIFICATION ALGORITHM; CONFOCAL MICROSCOPY; CONJUNCTIVA DISEASE; CONSERVATIVE TREATMENT; CONTACT LENS; CORNEA NEOVASCULARIZATION; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRY EYE; EYE DISEASE; EYE INFLAMMATION; EYE SURGERY; EYE TOXICITY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KERATOPLASTY; LAMELLAR KERATOPLASTY; LIMBAL STEM CELL TRANSPLANTATION; MEIBOMIAN GLAND; OCULAR SURFACE DISEASE; ORGAN INJURY; PATHOPHYSIOLOGY; PENETRATING KERATOPLASTY; POSTOPERATIVE CARE; RESPIRATORY TRACT DISEASE; REVIEW; SEBACEOUS GLAND DISEASE; SKIN MANIFESTATION; STEM CELL TRANSPLANTATION; TARSORRHAPHY; TISSUE TRANSPLANTATION; TREATMENT OUTCOME;

EID: 80051763177     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(11)70026-X     Document Type: Review

References (174)

1. Blodi FC . Mustard gas keratopathy. Int Ophthalmol Clin 1971;11:1-13
2. Solberg Y, Alcalay M, Belkin M. Ocular injury by mustard gas. Surv Ophthalmol 1997;41:461-466 (Pubitemid 27280157)
3. Javadi MA, Yazdani S, Sajjadi H, et al. Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 2005;112:617-625 (Pubitemid 41108862)
4. Safarinejad MR, Moosavi SA, Montazeri B. Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. Mil Med 2001;166:67-70 (Pubitemid 32097109)
5. Mann I. A study of eighty-four cases of delayed mustard gas keratitis fitted with contact lenses. Br J Ophthalmol 1944;28:441-447
6. Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 2006;31:1-5
7. Smith KJ, Skelton H. Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II. Skinmed 2003;2:215-221
8. Smith KJ, Skelton H. Chemical warfare agents: their past and continuing threat and evolving therapies. Part II of II. Skinmed 2003;2:297-303
9. Dahl H, Gluud B, Vangsted P, Norn M. Eye lesions induced by mustard gas. Acta Ophthalmol Suppl 1985;173:30-31 (Pubitemid 16249865)
10. Watson AP, Griffin GD. Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect 1992;98:259-280 (Pubitemid 23061815)
11. Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 1987;19:330-333
12. Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol2005;19:297-315 (Pubitemid 40769451)
13. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005;19:713-721 (Pubitemid 43822007)
14. Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 1996;48:289-326
15. Smith KJ, Hurst CG, Moeller RB, et al. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995;32(5 Pt 1):765-776
16. Riley MV, Meyer RF, Yates EM. Glutathione in the aqueous humor of human and other species. Invest Ophthalmol Vis Sci 1980;19:94-96
17. Kadar T, Turetz J, Fishbine E, et al. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits. Curr Eye Res 2001;22:42-53 (Pubitemid 32679491)
18. Black RM, Brewster K, Clarke RJ, et al. Biological fate of sulphur mustard, 1,1'-thiobis(2-chloroethane): isolation and identification of urinary metabolites following intraperitoneal administration to rat. Xenobiotica 1992;22:405-418
19. Black RM, Read RW. Detection of trace levels of thiodiglycol in blood, plasma and urine using gas chromatography-electron-capture negative-ion chemical ionisation mass spectrometry. J Chromatogr 1988;449:261-270
20. Black RM, Read RW. Biological fate of sulphur mustard, 1,1'-thiobis(2- chloroethane): identification of beta-lyase metabolites and hydrolysis products in human urine. Xenobiotica 1995;25:167-173
21. Wils ER, Hulst AG, de Jong AL, et al. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol 1985;9:254-257 (Pubitemid 16234476)
22. Wils ER, Hulst AG, van Laar J. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas, Part II. J Anal Toxicol 1988;12:15-19 (Pubitemid 18037400)
23. Black RM, Clarke RJ, Harrison JM, Read RW. Biological fate of sulphur mustard: identification of valine and histidine adducts in haemoglobin from casualties of sulphur mustard poisoning. Xenobiotica 1997;27:499-512 (Pubitemid 27220181)
24. Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol 2002;184:116-126 (Pubitemid 35339395)
25. Benschop HP, van der Schans GP, Noort D, et al. Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict. J Anal Toxicol 1997;21:249-251 (Pubitemid 27349041)
26. Fidder A, Moes GW, Scheffer AG, et al. Synthesis, characterization, and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood. Chem Res Toxicol 1994;7:199-204
27. Fidder A, Noort D, de Jong LP, et al. N7-(2-hydroxyethylthioethyl)- guanine: a novel urinary metabolite following exposure to sulphur mustard. Arch Toxicol 1996;70:854-5
28. Langenberg JP, van der Schans GP, Spruit HE, et al. Toxicokinetics of sulfur mustard and its DNA-adducts in the hairless guinea pig. Drug Chem Toxicol 1998;21 Suppl 1:131-47
29. van der Schans GP, Scheffer AG, Mars-Groenendijk RH, et al. Immunochemical detection of adducts of sulfur mustard to DNA of calf thymus and human white blood cells. Chem Res Toxicol 1994;7:408-413 (Pubitemid 24150102)
30. Livingston PC, Walker HM. A study of the effects of liquid mustard gas upon the eyes of rabbits and of certain methods of treatment. Br J Ophthalmol 1940;24:67-97
31. Gould NS, White CW, Day BJ. A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection. J Pharmacol Exp Ther 2009;328:732-739
32. Laskin JD, Black AT, Jan YH, et al. Oxidants and antioxidants in sulfur mustard-induced injury. Ann N Y Acad Sci 2010;1203:92-100
33. Jampol LM, Axelrod A, Tessler H. Pathways of the eye's response to topical nitrogen mustard. Invest Ophthalmol 1976;15:486-489
34. Borak J, Sidell FR . Agents of chemical warfare: sulfur mustard. Ann Emerg Med 1992;21:303-308
35. Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M. Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Experiment Ophthalmol 2006;34:342-346
36. Wheeler GP. Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res 1962;22:651-688
37. Graham JS, Schomacker KT, Glatter RD, et al. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002;28:719-730 (Pubitemid 35425415)
38. Requena L, Requena C, Sanchez M, et al. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 1988;19:529-36
39. Ruhl CM, Park SJ, Danisa O, et al. A serious skin sulfur mustard burn from an artillery shell. J Emerg Med 1994;12:159-66
40. Savage JR, Breckon G. Differential effects of sulphur mustard on S-phase cells of primary fibroblast cultures from Syrian hamsters. Mutat Res 1981;84:375-387 (Pubitemid 12248992)
41. Gilman A, Philips FS. The biological actions and therapeutic applications of the B-chloroethyl amines and sulfides. Science 1946;103(2675):409-436
42. Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 1989;27:419-435 (Pubitemid 19225356)
43. Lindahl T. DNA glycosylases, endonucleases for apurinic/apyrimidinic sites, and base excision-repair. Prog Nucleic Acid Res Mol Biol 1979;22:135-192
44. Crathorn AR, Roberts JJ. Mechanism of the cytotoxic action of alkylating agents in mammalian cells and evidence for the removal of alkylated groups from deoxyribonucleic acid. Nature 1966;211(5045):150-153
45. Gross CL, Meier HL, Papirmeister B, et al. Sulfur mustard lowers nicotinamide adenine dinucleotide concentrations in human skin grafted to athymic nude mice. Toxicol Appl Pharmacol 1985;81:85-90 (Pubitemid 16234037)
46. Elsayed NM, Omaye ST, Klain GJ, Korte DW Jr. Free radical-mediated lung response to the monofunctional sulfur mustard butyl 2-chloroethyl sulfide after subcutaneous injection. Toxicology 1992;72:153-165
47. McGahan MC, Bito LZ. The pathophysiology of the ocular microenvironment. I. Preliminary report on the possible involvement of copper in ocular inflammation. Curr Eye Res 1982;2):883-5
48. Nirankari VS, Varma SD, Lakhanpal V, Richards RD. Superoxide radical scavenging agents in treatment of alkali burns. An experimental study. Arch Ophthalmol 1981;99:886-887 (Pubitemid 11120565)
49. Pfister RR, Haddox JL, Yuille-Barr D. The combined effect of citrate/ ascorbate treatment in alkali-injured rabbit eyes. Cornea 1991;10:100-104
50. Banin E, Morad Y, Berenshtein E, et al. Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard. Invest Ophthalmol Vis Sci 2003;44:2966-2972 (Pubitemid 36759760)
51. Rankin PW, Jacobson MK, Mitchell VR, Busbee DL. Reduction of nicotinamide adenine dinucleotide levels by ultimate carcinogens in human lymphocytes. Cancer Res 1980;40:1803-1807
52. Eklow L, Moldeus P, Orrenius S. Oxidation of glutathione during hyDroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur J Biochem 1984;138:459-463
53. Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002;323:326-340 (Pubitemid 34651570)
54. Kadar T, Dachir S, Cohen L, et al. Ocular injuries following sulfur mustard exposure - pathological mechanism and potential therapy. Toxicology 2009;263:59-69
55. Hassan ZM, Ebtekar M. Modeling for immunosuppression by sulfur mustard. Int Immunopharmacol 2001;1:605-610
56. Ghotbi L, Hassan Z. The immunostatus of natural killer cells in people exposed to sulfur mustard. Int Immunopharmacol 2002;2:981-985 (Pubitemid 34756388)
57. Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 2005;5:1479-1485 (Pubitemid 40813304)
58. Smith KJ, Graham JS, Hamilton TA, et al. Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J Dermatol Sci 1997;15:173-182 (Pubitemid 27390883)
59. Baradaran-Rafii A, Javadi MA, Rezaei Kanavi M, et al. Limbal stem cell deficiency in chronic and delayed-onset mustard gas keratopathy. Ophthalmology 2010;117:246-252
60. Rezaei Kanavi M, Javadi A, Javadi MA. Chronic and delayed mustard gas keratopathy: a histopathologic and immunohistochemical study. Eur J Ophthalmol 2010;20:839-843
61. Milhorn D, Hamilton T, Nelson M, McNutt P. Progression of ocular sulfur mustard injury: development of a model system. Ann N Y Acad Sci 2010;1194:72-80
62. Yokoyama WM. Recognition structures on natural killer cells. Curr Opin Immunol 1993;5:67-73
63. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006;99:273-282 (Pubitemid 44578902)
64. Rice P. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol Rev 2003;22:111-118
65. Momeni AZ, Aminjavaheri M. Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinical study. Int J Dermatol 1994;33:184-187 (Pubitemid 24108781)
66. Inada S, Hiragun K, Seo K, Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure. J Dermatol 1978;5:49-60 (Pubitemid 8353847)
67. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005;214:198-209 (Pubitemid 41406260)
68. Khateri S, Ghanei M, Keshavarz S, et al. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45:1136-1143 (Pubitemid 37420858)
69. Freitag L, Firusian N, Stamatis G, Greschuchna D. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest 1991;100:1436-1441
70. Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg 1984;Suppl:254-259
71. Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 2005;17:587-592
72. Aghanouri R, Ghanei M, Aslani J, et al. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 2004;287:L1160-4
73. Bagheri MH, Hosseini SK, Mostafavi SH, Alavi SA. High-resolution CT in chronic pulmonary changes after mustard gas exposure. Acta Radiol 2003;44:241-245
74. Beheshti J, Mark EJ, Akbaei HM, et al. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 2006;202:739-744 (Pubitemid 44356424)
75. Bijani K, Moghadamnia AA . Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 2002;53:422-424 (Pubitemid 36015997)
76. Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997;112:734-738
77. Emad A, Rezaian GR. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 1999;115:1346-1351
78. Ghanei M, Akhlaghpoor S, Moahammad MM, Aslani J. Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 2004;16:845-849 (Pubitemid 39447340)
79. Ghanei M, Fathi H, Mohammad MM, et al. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 2004;16:491-495 (Pubitemid 38923912)
80. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004;52:164-169 (Pubitemid 39361117)
81. Beebe GW. Lung cancer in World War I veterans: possible relation to mustard-gas injury and 1918 influenza epidemic. J Natl Cancer Inst 1960;25:1231-1252
82. Easton DF, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 1988;45:652-659
83. Zojaji R, Balali-Mood M, Mirzadeh M, et al. Delayed head and neck complications of sulphur mustard poisoning in Iranian veterans. J Laryngol Otol 2009;123:1150-1154
84. Ghanei M, Vosoghi AA . An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect 2002;110:519-521 (Pubitemid 34546513)
85. Manning KP, Skegg DC, Stell PM, Doll R. Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol Allied Sci 1981;6:165-170 (Pubitemid 12198157)
86. Wada S, Miyanishi M, Nishimoto Y, et al. Mustard gas as a cause of respiratory neoplasia in man. Lancet 1968;1(7553):1161-1163
87. Takeshima Y, Inai K, Bennett WP, et al. p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis 1994;15:2075-2079 (Pubitemid 24317460)
88. Jafarinasab MR, Zarei-Ghanavati S, Kanavi MR, et al. Confocal microscopy in chronic and delayed mustard gas keratopathy. Cornea;29:889-894
89. Geeraets WJ, Abedi S, Blanke RV. Acute corneal injury by mustard gas. South Med J 1977;70:348-350 (Pubitemid 8082522)
90. Mann I, Pullinger BD. A study of mustard gas lesions of the eyes of rabbits and men: (Section of Ophthalmology). Proc R Soc Med 1942;35:229-244
91. Pleyer U, Sherif Z, Baatz H, Hartmann C. Delayed mustard gas keratopathy: clinical findings and confocal microscopy. Am J Ophthalmol 1999;128:506-507 (Pubitemid 29479327)
92. Blodi FC . Delayed mustard-gas keratopathy. Am J Ophthalmol 1953;36:1575-1576
93. Mann I, Pullinger BD. The pathology of cholesterin and fat deposition in mustard gas injuries of the cornea. Br J Ophthalmol 1942;26:503-507
94. English F, Bennett Y. The challenge of mustard-gas keratopathy. Med J Aust 1990;152:55-56
95. Javadi MA, Baradaran-Rafii A. Living-related conjunctival-limbal allograft for chronic or delayed-onset mustard gas keratopathy. Cornea 2009;28:51-57
96. Javadi MA, Yazdani S, Kanavi MR, et al. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 2007;26:1074-1078 (Pubitemid 47480688)
97. Maumenee AE, Scholz RO. The histopathology of the ocular lesions produced by the sulfur and nitrogen mustard. Bull Johns Hopkins Hosp 1948;82:121-147
98. Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998;39:18-22
99. Applegate LA, Ley RD. DNA damage is involved in the induction of opacification and neovascularization of the cornea by ultraviolet radiation. Exp Eye Res 1991;52:493-497
100. Campbell FW, Michaelson IC. Blood-vessel formation in the cornea. Br J Ophthalmol 1949;33:248-255
101. Eliason JA. Leukocytes and experimental corneal vascularization. Invest Ophthalmol Vis Sci 1978;17:1087-1095
102. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998;43:245-269
103. Sonoda K, Sakamoto T, Yoshikawa H, et al. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Invest Ophthalmol Vis Sci 1998;39:2245-2251 (Pubitemid 28485635)
104. Amir A, Turetz J, Chapman S, et al. Beneficial effects of topical antiinflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol 2000;20 Suppl 1:S109-14
105. Ormerod LD, Abelson MB, Kenyon KR. Standard models of corneal injury using alkali-immersed filter discs. Invest Ophthalmol Vis Sci 1989;30:2148-2153 (Pubitemid 19259917)
106. Furlow B. Biological, chemical and radiological terrorism. Radiol Technol 2003;75:91-107; quiz 8-10
107. Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 2009;263:9-11
108. Lopez-Garcia JS, Rivas L, Garcia-Lozano I. [Corneal epithelium squamous metaplasia determination as diagnostic factor in limbal deficiency]. Arch Soc Esp Oftalmol 2006;81:281-288Spanish
109. Lagali N, Fagerholm P. Delayed mustard gas keratitis: clinical course and in vivo confocal microscopy findings. Cornea 2009;28:458-462
110. Wilson SE, Mohan RR, Ambrosio R Jr, et al. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001;20:625-637 (Pubitemid 32695343)
111. Smith KJ. The prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these finding to other dermatologic conditions and wound healing. Dermatol Clin 1999;17:41-60, viii. (Pubitemid 29062076)
112. Chiesman WE. Lesions due to vesicants: diagnosis and treatment. Br Med J 1944;2(4359):109-112
113. Murray VS, Volans GN. Management of injuries due to chemical weapons. Br Med J 1991;302(6769):129-130
114. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991;127:1207-1213
115. Callaway S, Pearce KA. Protection against systemic poisoning by mustard gas, di(2-chloroethyl) sulphide, by sodium thiosulphate and thiocit in the albino rat. Br J Pharmacol Chemother 1958;13:395-8
116. Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocul Surf 2004;2:201-211 (Pubitemid 41263870)
117. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004;49:51-77 (Pubitemid 38056624)
118. Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction. Cornea 2005;24:643-653
119. Grueterich M, Espana EM, Tseng SC. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol 2003;48:631-646 (Pubitemid 37386280)
120. Sippel KC, Ma JJ, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol 2001;12:269-281 (Pubitemid 32751684)
121. Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocul Surf 2004;2:177-187 (Pubitemid 41263868)
122. Fu Y, Gregory DG, Sippel KC, et al. The ophthalmologist's role in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis. Ocul Surf 2010;8:193-203
123. Arora R, Mehta D, Jain V. Amniotic membrane transplantation in acute chemical burns. Eye (Lond) 2005;19:273-278
124. Kheirkhah A, Johnson DA, Paranjpe DR, et al. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol 2008;126:1059-1066
125. Meller D, Pires RT, Mack RJ, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 2000;107:980-989; discussion 90
126. Prabhasawat P, Tesavibul N, Prakairungthong N, Booranapong W. Efficacy of amniotic membrane patching for acute chemical and thermal ocular burns. J Med Assoc Thai 2007;90:319-326 (Pubitemid 46377170)
127. Tejwani S, Kolari RS, Sangwan VS, Rao GN. Role of amniotic membrane graft for ocular chemical and thermal injuries. Cornea 2007;26:21-26 (Pubitemid 46041559)
128. Kheirkhah A, Casas V, Raju VK, Tseng SC. Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency. Am J Ophthalmol 2008;145:787-794
129. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res 2004;78:433-446
130. Liang L, Sheha H, Li J, Tseng SC. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond) 2009;23:1946-1953
131. Liang L, Sheha H, Tseng SC. Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Arch Ophthalmol 2009;127:1428-1434
132. Meller D, Tseng SC. [Reconstruction of the conjunctival and corneal surface. Transplantation of amnionic membrane]. Ophthalmologe 1998;95:805-813German
133. Sangwan VS, Tseng SC. New perspectives in ocular surface disorders. An integrated approach for diagnosis and management. Indian J Ophthalmol 2001;49:153-168 (Pubitemid 33708681)
134. Tseng SC. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep 2001;21:481-489 (Pubitemid 34211831)
135. Alio JL, Abad M, Scorsetti DH. Preparation, indications and results of human amniotic membrane transplantation for ocular surface disorders. Expert Rev Med Devices 2005;2:153-160
136. Hanada K, Shimazaki J, Shimmura S, Tsubota K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol 2001;131:324-331
137. Espana EM, Di Pascuale M, Grueterich M, et al. Keratolimbal allograft in corneal reconstruction. Eye 2004;18:406-17
138. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002;109:1159-1166 (Pubitemid 34546927)
139. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol 1999;83:414-419 (Pubitemid 29161181)
140. Daya SM, Ilari FA. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 2001;108:126-133; discussion 33-4
141. Kim JY, Djalilian AR, Schwartz GS, Holland EJ. Ocular surface reconstruction: limbal stem cell transplantation. Ophthalmol Clin North Am 2003;16:67-77 (Pubitemid 36384127)
142. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 1999;340:1697-1703 (Pubitemid 29252597)
143. Javadi MA, Jafarinasab MR, Feizi S, et al. Management of mustard gas-induced limbal stem cell deficiency and keratitis. Ophthalmology Mar 2011 [Epub ahead of print]
144. Alio JL, Shah S, Barraquer C, et al. New techniques in lamellar keratoplasty. Curr Opin Ophthalmol 2002;13:224-9
145. Luengo-Gimeno F, Tan DT, Mehta JS. Evolution of deep anterior lamellar keratoplasty (DAL K). Ocul Surf 2011;9:98-110
146. Reis A, Birnbaum F, Reinhard T. [Systemic immunosuppressives after penetrating keratoplasty]. Ophthalmologe 2007;104:373-380German
147. Bigar F, Herbort CP. Corneal transplantation. Curr Opin Ophthalmol 1992;3:473-481
148. Pleyer U. [Immunomodulation in penetrating keratoplasty. Current status and perspectives]. Ophthalmologe 2003;100:1036-1044German
149. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 2003;110:125-130
150. Cauchi PA, Ang GS, Azuara-Blanco A, Burr JM. A systematic literature review of surgical interventions for limbal stem cell deficiency in humans. Am J Ophthalmol 2008;146:251-259
151. Boratynska M, Banasik M, Patrzalek D, Klinger M. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Ann Transplant 2006;11:51-56
152. Dua HS, Azuara-Blanco A. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol 1999;47:3-9
153. Hamrah P. High-risk penetrating keratoplasty. Arch Soc Esp Oftalmol 2005;80:5-7
154. Koay PY, Lee WH, Figueiredo FC . Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 2005;24:292-296 (Pubitemid 40418338)
155. Reinhard T, Mayweg S, Sokolovska Y, et al. Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study. Transpl Int 2005;18:703-8
156. Richter MN, Wachtlin J, Bechrakis NE, Hoffmann F. Keratoplasty after mustard gas injury: clinical outcome and histology. Cornea 2006;25:467-469
157. Williams RN, Bhattacherjee P. Inhibition of the acute ocular responses to nitrogen mustard by colchicine. Exp Eye Res 1984;39:721-729 (Pubitemid 15199829)
158. Gonzalez GG, Gallar J, Belmonte C. Influence of diltiazem on the ocular irritative response to nitrogen mustard. Exp Eye Res 1995;61:205-212
159. Vijayaraghavan R, Sugendran K, Pant SC, et al. Dermal intoxication of mice with bis(2-chloroethyl)sulphide and the protective effect of flavonoids. Toxicology 1991;69:35-42
160. Wormser U, Brodsky B, Reich R. Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch Toxicol 2002;76:119-121 (Pubitemid 34251564)
161. Wormser U, Sintov A, Brodsky B, Nyska A. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions. Toxicol Appl Pharmacol 2000;169:33-39
162. Vojvodic V, Milosavljevic Z, Boskovic B, Bojanic N. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundam Appl Toxicol 1985;5(6 Pt 2):S160-S168 (Pubitemid 16134977)
163. Papirmeister B, Gross CL, Meier HL, et al. Molecular basis for mustardinduced vesication. Fundam Appl Toxicol 1985;5(6 Pt 2):S134-S149
164. Sosne G, Chan CC, Thai K, et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 2001;72:605-608 (Pubitemid 32977230)
165. Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-299 (Pubitemid 34948404)
166. Sosne G, Christopherson PL, Barrett RP, Fridman R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci 2005;46:2388-2395 (Pubitemid 43119484)
167. Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta-4 and the eye: I can see clearly now the pain is gone. Ann N Y Acad Sci 2007;1112:114-122 (Pubitemid 47598645)
168. Sosne G, Qiu P, Christopherson PL, Wheater MK. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res 2007;84:663-669 (Pubitemid 46420439)
169. Yarmola EG, Klimenko ES, Fujita G, Bubb MR. Thymosin beta4: actin regulation and more. Ann N Y Acad Sci 2007;1112:76-85
170. Sawyer TW, Risk D. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes. Toxicol Appl Pharmacol 2000;163:75-85 (Pubitemid 30111979)
171. Ghanei M, Shohrati M, Jafari M, et al. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 2008;103:428-432
172. Kumar O, Sugendran K, Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 2001;134:1-12 (Pubitemid 32204424)
173. McClintock SD, Hoesel LM, Das SK, et al. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 2006;26:126-131
174. McClintock SD, Till GO, Smith MG, Ward PA. Protection from half-mustard-gas-induced acute lung injury in the rat. J Appl Toxicol 2002;22:257-262 (Pubitemid 34830750)